Literature DB >> 17631398

Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.

Adelina Gama1, Joana Paredes, Fátima Gärtner, Anabela Alves, Fernando Schmitt.   

Abstract

Cadherin-catenin complexes play a critical role in intercellular adhesion, and their altered expression has been implicated in tumour progression. In this study, the expression of E-cadherin, P-cadherin and beta-catenin was analysed in 65 canine malignant mammary tumours and correlated with clinicopathological parameters, proliferation and survival. Reduction in E-cadherin expression was significantly associated with increased tumour size, high histological and invasion grades, lymph node metastasis and high mitotic index. Reduced beta-catenin expression was associated with high histological and invasion grades. Anomalous expression of P-cadherin was only associated with invasion. In 39 cases for which follow-up data were available, reduced E-cadherin and beta-catenin expression was significantly associated with shorter overall survival and disease free survival. Abnormal expression of adhesion molecules is a common phenomenon in canine mammary malignant tumours and may play a central role in tumour progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17631398     DOI: 10.1016/j.tvjl.2007.05.024

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  16 in total

1.  Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification.

Authors:  A Gama; A Alves; F Schmitt
Journal:  Virchows Arch       Date:  2008-08-02       Impact factor: 4.064

2.  Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles.

Authors:  Robert Klopfleisch; Dido Lenze; Michael Hummel; Achim D Gruber
Journal:  BMC Cancer       Date:  2010-11-09       Impact factor: 4.430

3.  Cadherin cell adhesion system in canine mammary cancer: a review.

Authors:  Adelina Gama; Fernando Schmitt
Journal:  Vet Med Int       Date:  2012-08-22

4.  Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.

Authors:  Michèle Spoerri; Franco Guscetti; Sonja Hartnack; Alois Boos; Christine Oei; Orsolya Balogh; Renata M Nowaczyk; Erika Michel; Iris M Reichler; Mariusz P Kowalewski
Journal:  BMC Vet Res       Date:  2015-09-15       Impact factor: 2.741

5.  Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas.

Authors:  Ana Catarina Figueira; Catarina Gomes; Joana Tavares de Oliveira; Hugo Vilhena; Júlio Carvalheira; Augusto J F de Matos; Patrícia Dias Pereira; Fátima Gärtner
Journal:  BMC Vet Res       Date:  2014-11-26       Impact factor: 2.741

Review 6.  Molecular Signaling of Progesterone, Growth Hormone, Wnt, and HER in Mammary Glands of Dogs, Rodents, and Humans: New Treatment Target Identification.

Authors:  Elpetra P M Timmermans-Sprang; Ana Gracanin; Jan A Mol
Journal:  Front Vet Sci       Date:  2017-04-13

7.  Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry.

Authors:  Francesco Sassi; Cinzia Benazzi; Gastone Castellani; Giuseppe Sarli
Journal:  BMC Vet Res       Date:  2010-01-28       Impact factor: 2.741

8.  P-cadherin expression in feline mammary tissues.

Authors:  Ana Catarina Figueira; Ana Sofia Teodósio; Júlio Carvalheira; Manuela Lacerda; Augusto de Matos; Fátima Gärtner
Journal:  Vet Med Int       Date:  2012-10-03

Review 9.  P-cadherin expression in breast cancer: a review.

Authors:  Joana Paredes; Ana Luísa Correia; Ana Sofia Ribeiro; André Albergaria; Fernanda Milanezi; Fernando C Schmitt
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

10.  Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expression.

Authors:  Ana Gracanin; Elpetra P M Timmermans-Sprang; Monique E van Wolferen; Nagesha A S Rao; Juraj Grizelj; Silvijo Vince; Eva Hellmen; Jan A Mol
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.